UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
This intro outlines the main advantages of a total return index, emphasizing how it reflects real returns for portfolios that reinvest dividends.
24,441 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Amundi, Europe's biggest asset manager, launches a UCITS-compliant Solana fund in partnership with SPiko Finance, mar...
The EEOC plans to end federal demographics collection used to monitor workplace bias, a shift that could alter how di...
MoonPay seals its fourth acquisition of the year, bringing Decent into the fold as it launches MoonPay Trade to strea...
SpaceX’s IPO filing reveals a record-height valuation and a warning: Elon Musk’s media presence and cross-venture tie...
ON Semiconductor climbs to fresh highs in 2026 as AI data-center demand and GaN power tech power a strong cash flow-l...
A new AI coaching platform is launching to give every loan officer a personalized, on-demand coach. Early pilots show...
Oklo edges toward its first commercial nuclear power with government negotiations and a European funding alliance, ex...
Citigroup's Jane Fraser tops the 2026 Fortune Most Powerful Women list as 11 CFOs join the ranks, underscoring financ...
The insurance backdrop is stabilizing in mid-2026, but homeowners coverage costs stay stubbornly high. Builders and l...
Netflix reports a strong Q1 2026, lifting free cash flow guidance and accelerating ad revenue. Analysts see a path to...
MLB owners rolled out a formal salary cap plan, marking a rare shift in labor talks as the 2027 season looms. The mov...